What FATRO does

FATRO S.p.A. is an Italian veterinary pharmaceutical company founded in 1947 in Forlì by Gualtiero Zaini (pharmacist and veterinarian) and his son Corrado Zaini (chemist), now headquartered and manufacturing in Ozzano dell'Emilia (Bologna). The company researches, develops, manufactures, and distributes veterinary pharmaceuticals, vaccines, feed additives, hygiene products, and diagnostics for both food-producing animals (cattle, pigs, sheep, rabbits, poultry, fish) and companion animals. With a portfolio exceeding 250 products and the position of Italy's largest animal health business, FATRO distributes through 7 wholly-owned international subsidiaries (Spain, Greece, Poland, Czechia, Argentina, Uruguay, India), a majority stake in Turkey's Güneşli Aşılı, and a broader distributor network reaching over 90 countries.

FATRO's portfolio is anchored by several proprietary technologies, including the patented Afilaria SR microsphere delivery system for chrono-programmed moxidectin release enabling single annual filariasis prevention in companion animals, proprietary vaccine strains (BIO-VAC SGP 695 for fowl typhoid/Salmonella, BIO-VAC NDV 6/10 for Newcastle disease, AD LIVE-SUIVAX for Aujeszky's disease), a rapid mastitis diagnostic test delivering results in 10-12 hours (claimed to reduce antibiotic usage by 50-70%), and the QL-A02 leishmaniasis pipeline candidate acquired through the 2022 Quadrel acquisition. The company sells exclusively to veterinarians and pharmacists through a password-protected B2B e-commerce portal (ordini.fatro.it), supplemented by direct field sales through subsidiaries, the VetsApp mobile application, and the long-running Fatroagenda annual reference calendar published since 1980.

FATRO operates as a privately-held, family-owned company structured as a single-shareholder società con socio unico. Revenue is generated through B2B unit sales of pharmaceutical, vaccine, feed additive, and diagnostic products, with no public pricing disclosed. Recent growth has been driven by the companion animal segment (Afilaria SR), which has delivered double-digit growth for five consecutive years, and by inorganic moves including the 2022 Quadrel acquisition (R&D pipeline) and the 2024 Güneşli Aşılı acquisition (Turkish market direct presence). IHS Markit estimated 2022 turnover at approximately €200 million (~$208 million), positioning FATRO as a mid-sized European animal health player operating under a "One Health" philosophy linking animal and human health.

Name

FATRO

Legal name

FATRO S.p.A.

Website

https://fatro.it

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

11–50 employees

Short description

FATRO S.p.A. is an Italian veterinary pharmaceutical company that researches, develops, manufactures, and distributes pharmaceuticals, vaccines, feed additives, and diagnostics for food-producing and companion animals across 90+ countries via 8 international subsidiaries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Other Animal Food Manufacturing (311119)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Veterinary Vaccines (HLAIAEAH), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Veterinary pharmaceuticals
• Animal vaccines
• Livestock health products
• Veterinary drug manufacturing
• Companion animal care

Headquarters

HQ city

Bologna

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceuticals: Sale of pharmaceutical drugs for food-producing animals and companion animals including antimicrobials, anti-inflammatories, gynecologicals, sedatives, hepatoprotectors, vitamins, minerals, and antiparasitics.
2. Veterinary Vaccines: Production and sale of vaccines for cattle, pigs, sheep, rabbits, poultry, and fish.
3. Feed Additives and Medicated Premix: Complementary feeds and medicated premixes for animal nutrition and health.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

FATRO S.p.A. researches, develops, manufactures, and sells veterinary pharmaceutical drugs and vaccines for food-producing animals (cattle, pigs, sheep, poultry, fish) and companion animals. Its portfolio of more than 250 products spans antibiotics, anti-inflammatories, gynecologicals, sedatives, vitamins/minerals, antiparasitics, vaccines, feed additives, medicated premixes, hygiene/disinfectants, and a rapid bovine mastitis diagnostic test. Flagship offerings include the Afilaria SR single-injection filariasis prevention product for companion animals and patented veterinary vaccine lines such as BIO-VAC SGP 695, BIO-VAC NDV 6/10, and AD LIVE-SUIVAX.

Product overview

FATRO is an Italian veterinary pharmaceutical company offering over 250 products for the prevention and treatment of large and companion animals. The product portfolio is organized into several categories: SPECIALTÀ (pharmaceutical specialties including antibiotics, anti-inflammatories, antiparasitics, and sedatives), VACCINI (vaccines for cattle, pigs, sheep, rabbits, poultry, and fish including patented vaccines like BIO-VAC and AD LIVE-SUIVAX), MANGIMI COMPLEMENTARI (feed additives), IGHIENE E DISINFETTANTI (hygiene and disinfectants), TEST RAPIDO MASTITE BOVINA (rapid mastitis diagnostic), and specialized products for feed manufacturers. Key flagship products include AFILARIA SR for companion animal filariasis prevention using patented microsphere technology, and various FATROXIMIN/CEFAXIMIN antibiotic intramammary formulations. The pipeline includes QL-A02 for leishmaniasis treatment. Products are exported to over 90 countries through subsidiaries and distributors.

Differentiator

Problem solved

Functional benefit

Brands

• Afilaria SR: Flagship companion animal product for the prevention of filariasis through a single annual injection using chrono-programed moxidectin delivery via microsphere technology patented by FATRO.
• VetsApp
• Fatroagenda
• Wildlife Collection Calendar

Products and services

• AFILARIA SR Flagship companion animal product for the prevention of filariasis via a single annual subcutaneous injection of chrono-programmed moxidectin delivered through patented microsphere technology. Sold exclusively to veterinarians and pharmacists.
• VACCINI - Veterinary Vaccines Range of veterinary vaccines for cattle, pigs, sheep, rabbits, poultry, and fish. Includes patented live attenuated and live deleted vaccines (BIO-VAC SGP 695, BIO-VAC NDV 6/10, AD LIVE-SUIVAX) for prevention of fowl typhoid, Salmonella Enteritidis, Newcastle disease, and Aujeszky's disease.
• SPECIALTÀ - Pharmaceutical Specialties Comprehensive range of veterinary pharmaceutical specialties including antibiotics/chemotherapeutics, intramammary lactation and dry-cow products, dry-cow sealant, anti-inflammatories, antipyretics/analgesics, gynecologicals, preanesthetics/sedatives, vitamins/minerals/reconstituents, detox/hepatoprotectors, choleretics/digestives, antianemics, and antiparasitics.
• TEST RAPIDO MASTITE BOVINA Rapid on-farm field test that identifies microorganisms involved in bovine mastitis within 10-12 hours, supporting targeted antibiotic treatment decisions and selective dry cow therapy to reduce antibiotic usage by 50-70%.
• MANGIMI COMPLEMENTARI - Complementary Feeds Complementary feed products for animal nutrition and health across food-producing species and companion animals.
• PRODOTTI PER MANGIMISTI - Products for Feed Manufacturers Specialized premix and medicated feed products supplied to feed manufacturers for incorporation into animal diets.
• IGIENE E DISINFETTANTI - Hygiene and Disinfectants Hygiene and disinfectant products for veterinary clinics, livestock facilities, and agricultural use.
• BIO-VAC SGP 695 Patented live attenuated vaccine (SGP695AV strain) administered via oral suspension for active immunization of poultry against fowl typhoid and Salmonella Enteritidis infection.
• BIO-VAC NDV 6/10 Patented vaccine using the NDV 6/10 strain for active immunization of chickens against Newcastle disease.
• AD LIVE-SUIVAX Patented live deleted vaccine based on the LomBart strain for active immunization of swine against Aujeszky's disease.
• FATROXIMIN / CEFAXIMIN-L Intramammary Range Antibiotic intramammary formulations (Dry Cow, Pessaries, IU Foam, Topic Spray variants) for treatment of mastitis and selective dry cow therapy in dairy cattle.

Quantifiable outcome

• 50-70% reduction in antibiotic usage for mastitis treatment through rapid testing approach
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Güneşli AşıcoreStrategic or Co-development Partner · 1 January 2024FATRO acquired majority stake in Güneşli Aşı, a Turkish company active in importation of veterinary pharmaceutical products. This represents a significant step in strengthening direct presence in the Turkish market, where FATRO was already active through distribution channels, consolidating position in Eastern Mediterranean.
• Quadrel (Scientists Consortium)coreStrategic or Co-development Partner · 16 November 2022FATRO acquired Quadrel, a collection of scientists from several European countries based in Modena. Quadrel owns intellectual property and patents for QL-A02, a drug candidate for trypanosomatidic infections including leishmaniasis, developed under the 7th European Framework Program with €7.6 million investment across 13 research centers.
• Fondazione Corrado e Bruno Maria ZainiminorOthersCorporate foundation supporting medical-scientific research, assistance to sick people, and projects in developing countries. Named after FATRO co-founder Corrado Zaini and his brother Bruno Maria.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/departmentc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FATRO